Evaluation of clinical significance of kallistatin and macrophage inflammatory protein-1b for the diagnosis of liver cirrhosis and hepatocellular carcinoma in Egyptian patients

[...]the early diagnosis of liver diseaseas is the only solution for this great problem [3]. [...]The final diagnosis of cirrhosis depends on the histological examination of liver tissue. [5] Series of new reliable biomarkers for early stages of liver cirrhosis and HCC is needed to improve clinical diagnosis and results. [...]the marker should be sensitive, easily measurable and minimally invasive. DISCUSSION Liver cirrhosis and hepatocellular carcinoma represent a worldwide global challenge. [...]liver transplantation is the most effective treatment for chronic liver diseases. According to this strategy, we assumed Kallistatin and chemokine CCl4 for evaluation as a prognostic markers for LC and HCC patients.